| 2004N-0115 - Prescription Drug Importation; Public Meeting | |||||||||||||||||||||||
| FDA Comment Number : | EC51 | ||||||||||||||||||||||
| Submitter : | Mr. Thomas Kubic | Date & Time: | 06/02/2004 09:06:58 | ||||||||||||||||||||
| Organization : | Pharmaceutical Security Institute | ||||||||||||||||||||||
| Drug Association | |||||||||||||||||||||||
| Category : | |||||||||||||||||||||||
| Issue Areas/Comments | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| I am pleased to take the opportunity to provide comments concerning the United States Department of Health and Human Services effort to identify issues and seek answers to the many vexing questions relating to the new legislation that will liberalize the importation of prescription drugs. For my comment please refer to the attached file.
| |||||||||||||||||||||||